Directory profiles that have not opted in. Name, email, and a private contact are not listed. 52 states. Last updated 2026-10-16. Counts are on the catalog.
Page 797. The contact email is not on this page.
- HALIDE BIOLOGICS, INC.
NIH R43: Targeted fluorination for improved pharmacology of enzyme replacement therapies
startup · IA · amount not stated · 2024-01-01
Directory profile (not opted in). scraped, medium. Source: Source. Updated 2026-01-01.
- TIBBLING TECHNOLOGIES LLC
NIH R43: SmartDrive: AI-Powered Mobile App for Real-Time Detection of Non-Disordered Drug Use in Drivers
startup · WA · amount not stated · 2024-01-01
Directory profile (not opted in). scraped, medium. Source: Source. Updated 2026-01-01.
- NANOMETICS, LLC
NIH R44: A Phase 2, randomized, double-blind, 4-arm, multicenter study to demonstrate the efficacy and safety of topical dosage formulations of a prescription drug product for actinic keratosis
startup · CA · amount not stated · 2024-01-01
Directory profile (not opted in). scraped, medium. Source: Source. Updated 2026-01-01.
- CARE PROGRESS, LLC
NIH R43: Leveraging Large Language Models to Enhance Regional Genomic Medicine eConsults
startup · MD · amount not stated · 2024-01-01
Directory profile (not opted in). scraped, medium. Source: Source. Updated 2026-01-01.
- MIXEDLCMEDIA LLC
NIH R41: Next-generation nanoflow LC column technology to enable high sensitivity proteomics of limited samples
startup · MA · amount not stated · 2024-01-01
Directory profile (not opted in). scraped, medium. Source: Source. Updated 2026-01-01.
- Endolynx Inc.
Form D history: Other Health Care
startup · NJ · amount not stated · 2023-03-06
Directory profile (not opted in). scraped, medium. Source: SEC EDGAR. Updated 2023-03-06.
- CAMBRIDGE MEDICAL TECHNOLOGIES LLC
NIH R44: Lactate Measurement Using a Novel Non-invasive Device
startup · MD · amount not stated · 2024-01-01
Directory profile (not opted in). scraped, medium. Source: Source. Updated 2026-01-01.
- Aperture Therapeutics
Aperture Therapeutics is focused on developing therapies for neurodegenerative diseases by leveraging genetic insights and machine learning to create oligonucleotide therapeutics that mimic protective gene variants.
startup · CA · amount not stated · 2024-01-01
Directory profile (not opted in). scraped, medium. Source: Source. Updated 2026-01-01.
- CERIA THERAPEUTICS, INC.
NIH R44: A Novel Anti-inflammatoryand Anti-oxidant Therapy for Treating Non-healing Diabetic Foot Ulcers
startup · AZ · amount not stated · 2024-01-01
Directory profile (not opted in). scraped, medium. Source: Source. Updated 2026-01-01.
- BASE PAIR BIOTECHNOLOGIES, INC.
NIH R44: Bench-top Reader and Aptamer-based Assay for Rapid, High-sensitivity Drug/Opiate Detection
startup · TX · amount not stated · 2024-01-01
Directory profile (not opted in). scraped, medium. Source: Source. Updated 2026-01-01.
- BIOAMP DIAGNOSTICS, INC.
NIH R43: Evolving the standard of care for carbapenem resistant infections, through the development of a phenotypic assay capable of DETECTing and classifying carbapenemases
startup · CA · amount not stated · 2024-01-01
Directory profile (not opted in). scraped, medium. Source: Source. Updated 2026-01-01.
- NAVIGATION SCIENCES, INC.
NIH R41: Targeted Localization and Optimized Surgical Resection for Lung Cancer
startup · MA · amount not stated · 2024-01-01
Directory profile (not opted in). scraped, medium. Source: Source. Updated 2026-01-01.
- ARTIFICIAL AXON LABS INC.
NIH R44: In vitro myelination assay modeling the environment of MS lesions for predictive discovery of remyelinating therapies
startup · MA · amount not stated · 2024-01-01
Directory profile (not opted in). scraped, medium. Source: Source. Updated 2026-01-01.
- Matrisome Bio
Matrisome Bio is a biotechnology company developing a therapeutic platform that uses nanobodies to target the extracellular matrix for the treatment of cancer and other chronic diseases.
startup · MA · amount not stated · 2024-01-01
Directory profile (not opted in). scraped, medium. Source: Source. Updated 2026-01-01.
- LO BIOSCIENCES, INC.
NIH R44: A novel remote blood separation device for at-home plasma collection for HIV-1 testing
startup · MD · amount not stated · 2024-01-01
Directory profile (not opted in). scraped, medium. Source: Source. Updated 2026-01-01.
- 37DEGREES, INC.
NIH R43: InVitreON: A compact and integrated platform for long-term neuronal culture incubation, recording and closed-loop stimulation
startup · IL · amount not stated · 2024-01-01
Directory profile (not opted in). scraped, medium. Source: Source. Updated 2026-01-01.
- EXPERIAD, LLC
NIH R44: Acuity - A Clinical Decision Support System for Applied Behavior Analysis
startup · HI · amount not stated · 2024-01-01
Directory profile (not opted in). scraped, medium. Source: Source. Updated 2026-01-01.
- Eikonizo Therapeutics
Eikonizo Therapeutics is developing oral, brain-penetrant, highly selective small molecule histone deacetylase 6 (HDAC6) inhibitors as disease-modifying therapeutics for neurodegenerative diseases, including amyotrophic lateral sclerosis (ALS), frontotemporal dementia (FTD), Park
startup · MA · amount not stated · 2024-01-01
Directory profile (not opted in). scraped, medium. Source: Source. Updated 2026-01-01.
- SCINTILLATION NANOTECHNOLOGIES, INC.
NIH R43: Nanoparticle Radioassay for Proteins in Native Membranes
startup · AZ · amount not stated · 2024-01-01
Directory profile (not opted in). scraped, medium. Source: Source. Updated 2026-01-01.
- QILIN BIO INC.
NIH R42: Next generation anti-cancer drugdelivering cement for bone metastasis patients
startup · MA · amount not stated · 2024-01-01
Directory profile (not opted in). scraped, medium. Source: Source. Updated 2026-01-01.
- ARETE BIOSCIENCES
NIH R43: Development of an ultrasensitive, rapid and portable nucleic acid based test for detection of acute Hepatitis C Virus infection at the point-of-care.
startup · IL · amount not stated · 2024-01-01
Directory profile (not opted in). scraped, medium. Source: Source. Updated 2026-01-01.
- ANELLEO, INC.
NIH R44: Innovative 3D Printed Intravaginal Ring AnelleO-PRO, the first Single Administration of Progesterone for Infertility
startup · NC · amount not stated · 2024-01-01
Directory profile (not opted in). scraped, medium. Source: Source. Updated 2026-01-01.
- ODMR TECHNOLOGIES, INC.
NIH R42: Diamond NMR spectrometer for microfluidic metabolite profiling
startup · CA · amount not stated · 2024-01-01
Directory profile (not opted in). scraped, medium. Source: Source. Updated 2026-01-01.
- Xyone Therapeutics, Inc.
Form D history: Biotechnology
startup · MA · amount not stated · 2021-10-28
Directory profile (not opted in). scraped, medium. Source: SEC EDGAR. Updated 2021-10-28.
- PRAEVIUM RESEARCH, INC.
NIH R44: Next generation MEMS-VCSEL technology for ultra-low-cost dental and periodontal swept source optical coherence tomography imaging
startup · CA · amount not stated · 2024-01-01
Directory profile (not opted in). scraped, medium. Source: Source. Updated 2026-01-01.
- LUMINA MEDICAL LLC
NIH R43: Innovative Vaginal Girth Adjustable Dilator with Precise Dilation Monitoring, designed to Significantly Improve Patient Pain Management in Pelvic Floor Disorder Treatment
startup · CA · amount not stated · 2024-01-01
Directory profile (not opted in). scraped, medium. Source: Source. Updated 2026-01-01.
- ORYGYN MEDICAL DEVICES, LLC
NIH R43: A simple device for office evaluation of tubal patency during the workup for infertility.
startup · OR · amount not stated · 2024-01-01
Directory profile (not opted in). scraped, medium. Source: Source. Updated 2026-01-01.
- HUMAN CELL CO
NIH R44: Optimizing NGF for Topical Treatment of Glaucoma
startup · IL · amount not stated · 2024-01-01
Directory profile (not opted in). scraped, medium. Source: Source. Updated 2026-01-01.
- Nostopharma, LLC
Form D history: Other Health Care
startup · MD · amount not stated · 2024-09-26
Directory profile (not opted in). scraped, medium. Source: SEC EDGAR. Updated 2024-09-26.
- CALADAN THERAPEUTICS, INC.
NIH R41: Meganuclease-mediated gene editing for durable control of HSV-2 infection
startup · AL · amount not stated · 2024-01-01
Directory profile (not opted in). scraped, medium. Source: Source. Updated 2026-01-01.
- BIOTARGET DX LLC
NIH R43: Dual-Platform Plasma Assay for Early Lung Cancer Detection in African Americans
startup · MD · amount not stated · 2024-01-01
Directory profile (not opted in). scraped, medium. Source: Source. Updated 2026-01-01.
- CLEARSIGHT THERAPEUTICS, INC.
NIH R43: Novel preservative-free eyedrop with antimicrobial and anti-inflammatory properties for treating Acute Infectious Conjunctivitis and Epidemic KeratoConjuntivitis (EKC)
startup · TX · amount not stated · 2024-01-01
Directory profile (not opted in). scraped, medium. Source: Source. Updated 2026-01-01.
- ARTERY THERAPEUTICS, INC.
NIH R44: Manufacturing of ABCA1 agonist small molecule peptide CS6253 to support chronic toxicology studies in Wistar rats and Cynomolgus monkeys
startup · CA · amount not stated · 2024-01-01
Directory profile (not opted in). scraped, medium. Source: Source. Updated 2026-01-01.
- LIBERATING TECHNOLOGIES, INC.
NIH R44: The Development of a Bimodal Walking-Running Prosthetic Foot
startup · MA · amount not stated · 2024-01-01
Directory profile (not opted in). scraped, medium. Source: Source. Updated 2026-01-01.
- PINNACLE TECHNOLOGY, INC
NIH R44: Functionalized Multi-Modal Tetrode Arrays for Real-Time, Site-Specific Neurochemical Monitoring
startup · KS · amount not stated · 2024-01-01
Directory profile (not opted in). scraped, medium. Source: Source. Updated 2026-01-01.
- GigaMune
GigaMune is a San Francisco biotechnology company developing a pipeline of in vivo cell therapies for cancer and inherited blood disorders, utilizing viral gene delivery vectors to overcome manufacturing bottlenecks.
startup · CA · amount not stated · 2024-01-01
Directory profile (not opted in). scraped, medium. Source: Source. Updated 2026-01-01.
- TAVO BIOTHERAPEUTICS, INC
NIH R44: Late-stage Pre-clinical Development and GMP Production of a First-in-Class Extended Release IOP-lowering Formulation
startup · TN · amount not stated · 2024-01-01
Directory profile (not opted in). scraped, medium. Source: Source. Updated 2026-01-01.
- TRITONX INC.
NIH R42: Clinical effectiveness of a wearable hydration device
startup · IL · amount not stated · 2024-01-01
Directory profile (not opted in). scraped, medium. Source: Source. Updated 2026-01-01.
- VORTEX MEDICAL INC.
NIH R44: Developing a novel vesico-amniotic shunt to treat fetal lower urinary tract obstruction
startup · CA · amount not stated · 2024-01-01
Directory profile (not opted in). scraped, medium. Source: Source. Updated 2026-01-01.
- GLYCYX MOR, INC.
NIH R44: A Phase 2 Trial of Axelopran Plus Pembrolizumab for the First-Line Treatment of Recurrent/Metastatic HNSCC That Is PD-L1 Positive (PD-L1CPS >1)
startup · CA · amount not stated · 2024-01-01
Directory profile (not opted in). scraped, medium. Source: Source. Updated 2026-01-01.